Skip to content

Ventricular Volume as Assessed by Cardiac Magnetic Resonance

MRI Assessment of the Effect of Preload on Ventricular Volumes and Function in Healthy Adult Volunteers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01678040
Enrollment
15
Registered
2012-09-03
Start date
2012-05-31
Completion date
2013-06-30
Last updated
2019-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmogenic Right Ventricular Cardiomyophathy (ARVC)

Keywords

Ventricular Volume, Cardiac Magnetic Resonance, Echocardiogram

Brief summary

One of the many uses of cardiac magnetic resonance (CMR) is the assessment of right ventricular (RV) volumes. There are a number of congenital heart defects and acquired conditions in which management decisions are fundamentally based on ventricular volumes. The gold standard for assessment of RV volume is CMR. It has better near-field resolution than echo and excellent contrast between the blood pool and the myocardium. CMR is more suitable to the irregular geometry of the RV. The objectives of this study are (1) to assess ventricular volumes in the fasting state and after oral hydration in order to assess the effect of fluid status on ventricular volumes as measured by CMR; (2) to evaluate the effect of hydration on ventricular volumes compared the effect of with inter-observer and intra-observer variability, and; (3) to evaluate the effects of chamber volume on chamber deformation, including strain and peak strain rate. This study hypothesizes that (1) hydration status has an effect on right and left heart volumes, measured by CMR in healthy volunteers; (2) the effect of volume status will be a more significant contributor to variability in RV volumetry than that of inter-observer variability and intra-observer variability, and; (3) atrial and Ventricular deformation corrected for chamber size or volume is more accurate than when uncorrected for volume.

Detailed description

1. To assess ventricular volumes in the fasting state and after oral hydration in order to assess the effect of fluid status on ventricular volumes as measured by CMR. 2. To evaluate the effect of hydration on ventricular volumes compared the effect of with inter-observer and intra-observer variability. 3. To evaluate the effects of chamber volume on chamber deformation, including strain and peak strain rate.

Interventions

None listed

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Participant must be healthy

Exclusion criteria

* Individuals who are unable to participate in an overnight fast will be excluded * Those with known or suspected structural heart disease will be excluded * A screening form to identify pre-existing cardiac conditions will be completed by the subject prior to participation in this study. If a pre-existing condition cardiac condition is identified, or suspected they will be excluded from the study. * If any functional abnormality is detected at any stage by echocardiography or by CMR the study will be terminated. Common anatomical variants, which are generally regarded as normal variants (such as a patent foramen ovale, or a persistent left superior vena cava) will not lead to exclusion from the study.

Design outcomes

Primary

MeasureTime frameDescription
Fluid StatusDay 1To assess ventricular volumes in the fasting state and after oral hydration in order to assess the effect of fluid status on ventricular volumes as measured by CMR.

Secondary

MeasureTime frameDescription
Chamber DeformationDay 1To evaluate the effects of chamber volume on chamber deformation, including strain and peak strain rate
HydrationDay 1To evaluate the effect of hydration on ventricular volumes compared the effect of with inter-observer and intra-observer variability.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026